These data suggest that the RHBDF1-PKCζ-importin β1 complex may have a utility to serve as a target for the development of therapeutic approaches aiming at curtailing the disruption of epithelial cell polarity and mammary gland normality in early stage of breast cancer development. The gene discussed is RHBDF1; the disease is breast carcinoma.